Shimotsuke, Japan

Katsumi Kasashima

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Jichi Medical University. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsumi Kasashima. Retrieved from https://idiyas.com/inventor/katsumi-kasashima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Katsumi Kasashima

Introduction

Katsumi Kasashima is a notable inventor based in Shimotsuke, Japan. He has made significant contributions to the field of mitochondrial function research. With a total of 2 patents, his work focuses on the regulation of mitochondrial-related diseases.

Latest Patents

One of his latest patents is centered around the mitochondrial function of prohibitin 2 (PHB2). This invention relates to a PHB2 gene regulator and a therapeutic drug for diseases associated with mitochondrial function. The implications of this research are profound, as it addresses critical health issues related to mitochondrial dysfunction.

Career Highlights

Katsumi Kasashima is affiliated with Jichi Medical University, where he continues to advance his research. His work has garnered attention in the scientific community, contributing to the understanding of mitochondrial biology.

Collaborations

Katsumi collaborates with Hitoshi Endo, enhancing the scope and impact of their research endeavors.

Conclusion

Katsumi Kasashima's innovative work in mitochondrial function and his contributions to therapeutic advancements highlight his importance in the field of medical research. His patents reflect a commitment to addressing significant health challenges through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…